The importance of blood pressure control in hypertensive patients with co-existing metabolic conditions such as type 2 diabetes mellitus.  Menarini International satellite Symposium: Hypertension and concurrent pathologies: is Nebivolol a suitable option?

Una Martin

The importance of blood pressure control in hypertensive patients with co-existing metabolic conditions such as type 2 diabetes mellitus. Menarini International satellite Symposium: Hypertension and concurrent pathologies: is Nebivolol a suitable option?

Sport, Exercise and Rehabilitation Sciences

Research output: Contribution to conference (unpublished) › Paper

Original language	English
Publication status	Published - 1 Jan 2002
Event	12th European Meeting on Hypertension - Duration: 1 Jan 2002 → …

Conference

Conference	12th European Meeting on Hypertension
Period	1/01/02 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{2a09c73b9c424d7ca035ea39684aff70,

title = "The importance of blood pressure control in hypertensive patients with co-existing metabolic conditions such as type 2 diabetes mellitus. Menarini International satellite Symposium: Hypertension and concurrent pathologies: is Nebivolol a suitable option?",

author = "Una Martin",

year = "2002",

month = jan,

day = "1",

language = "English",

note = "12th European Meeting on Hypertension ; Conference date: 01-01-2002",

}

The importance of blood pressure control in hypertensive patients with co-existing metabolic conditions such as type 2 diabetes mellitus. Menarini International satellite Symposium: Hypertension and concurrent pathologies: is Nebivolol a suitable option? / Martin, Una.
2002. Paper presented at 12th European Meeting on Hypertension.

Research output: Contribution to conference (unpublished) › Paper

TY - CONF

T1 - The importance of blood pressure control in hypertensive patients with co-existing metabolic conditions such as type 2 diabetes mellitus. Menarini International satellite Symposium: Hypertension and concurrent pathologies: is Nebivolol a suitable option?

AU - Martin, Una

PY - 2002/1/1

Y1 - 2002/1/1

M3 - Paper

T2 - 12th European Meeting on Hypertension

Y2 - 1 January 2002

ER -